Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 05-2021 | 02-2021 | 11-2020 | |
| Cash Flows From Operating Activities | |||
| Accounts receivable | 2 | -1 | -11 |
| Other Working Capital | -23 | -699 | 213 |
| Other Operating Activity | -1,588 | -748 | -350 |
| Operating Cash Flow | $-1,609 | $-1,449 | $-148 |
| Cash Flows From Investing Activities | |||
| Purchase Sale Intangibles | 0 | -1 | -12 |
| Investing Cash Flow | $0 | $-1 | $-12 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | 0 | 0 | -5 |
| Other Financing Activity | 465 | 7,513 | -172 |
| Financing Cash Flow | $465 | $7,513 | $-177 |
| Beginning Cash Position | 6,746 | 682 | 1,019 |
| End Cash Position | 5,602 | 6,746 | 682 |
| Net Cash Flow | $-1,144 | $6,064 | $-337 |
| Free Cash Flow | |||
| Operating Cash Flow | -1,609 | -1,449 | -148 |
| Capital Expenditure | N/A | -1 | -12 |
| Free Cash Flow | -1,609 | -1,449 | -160 |